Ventyx Biosciences earnings were -$124.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest VTYX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$27.4M, down 6.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VTYX reported annual earnings of -$135.1M, with -30% growth.
What were Ventyx Biosciences's earnings last quarter?
On VTYX's earnings call on Invalid Date, Ventyx Biosciences (NASDAQ: VTYX) reported Q1 2025 earnings per share (EPS) of -$0.39, up 37.1% year over year. Total VTYX earnings for the quarter were -$27.44 million. In the same quarter last year, Ventyx Biosciences's earnings per share (EPS) was -$0.62.
As of the last Ventyx Biosciences earnings report, Ventyx Biosciences is currently losing money. Ventyx Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$123.99 million, a 35.62% decrease year over year.
What was VTYX's earnings growth in the past year?
As of Ventyx Biosciences's earnings date in Invalid Date, Ventyx Biosciences's earnings has grown year over year. VTYX earnings in the past year totalled -$123.99 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.